4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-007490
President and CEO gave up 3,579 shares (to pay taxes)
- President and CEO acquired 10,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2019-02-01 | Option exercise | +10,800 | 920,924 | D | ||
| Walker Neal President and CEO | 2019-02-01 | Shares withheld for taxes | −3,579 | $6.96 | $24,910 | 917,345 | D |
| Derivatives | |||||||
| Walker Neal President and CEO | 2019-02-01 | Option exercise · Restricted Stock Units | −10,800 | 32,400 | D | ||
Loading xslF345X03/doc4.xml…